INNOVATEDIGNITY: Co-designing Digital Health Technologies With Older People in Homecare Settings.

NCT04884711 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 10

Last updated 2021-05-14

No results posted yet for this study

Summary

One of the crucial components of successful ageing is to live independently in old age. Yet in UK alone, nearly 300000 older people require assistance with 3 or more essential daily tasks like eating, bathing and mobility which compromises on their independent living. Additionally, in a crisis where health system in UK is already overstretched to its resources to combat the recent Coronavirus Disease 2019 (COVID-19) pandemic, allocating resources for regular homecare services has become challenging. In this situation, Digital Health Technologies (DHTs) can be a potential solution to promote healthy ageing, support psycho-social wellbeing and enhance independent living for older people. Such technologies comprise a wide range of products used in the health and care services including apps, software and online platforms to benefit people. Yet DHTs are barely adopted by older people as they do not reflect their actual user needs leading to poor appropriation of DHTs in homecare settings. The investigators aim to address this gap by involving older people living at the Leach Court, UK under the eco system of the Brighton \& Hove Digital Health Living Lab (BHLL) to co-design with us DHTs that addresses the barriers \& facilitators they face in adopting to DHTs. This participatory research approach has a qualitative study design which is sensitive to basic human values like 'dignity', appreciates that older people are 'expert of their experiences' and methodologically has phenomenological underpinnings gathering the researcher's understanding from the lived experiences of older people. This unique project, part of the European Union (EU) Horizon 2020 funded INNOVATEDIGNITY project, will be aiming to translate intangible human values like 'dignity' into tangible technology design through better understanding of the barriers \& facilitators older people face to DHTs adoption. With global population of older people increasing faster than all other age groups currently, this project stands to meet the future demands of the ageing population through dignity sensitive better designed DHTs .

This project is part of the Marie Skłodowska-Curie Actions (MSCA) Innovative Training Networks (ITN). This project has received funding from the European Union's H2020-MSCA-ITN-2018 programme under grant agreement No 813928.

Conditions

  • Dignity
  • Old Age; Debility
  • Healthy Aging
  • Digital Technology

Interventions

OTHER

No Interventions. Participants will be using their everyday digital health technologies.

The investigators will be involving older people to understand the barriers \& facilitators of digital health technology adoption for homebound older people. In this process no interventions will be given by us.

OTHER

In depth Interviews

In-depth interviews will be conducted to gather lived experiences of homebound older people.

OTHER

Focus Group Discussions

Focus Group Discussions will be used to create avenues to enhance dignity and human perspectives in digital designs for older people.

Sponsors & Collaborators

  • Brighton & Hove Digital Health Living Lab

    collaborator UNKNOWN
  • Nord University

    collaborator OTHER
  • University of Brighton

    lead OTHER

Principal Investigators

  • Prof.Kathleen Galvin, PhD · University of Brighton

  • Dr. Theofanis Fotis, PhD · University of Brighton

  • Prof.Lisbeth Uhrendfeldt, PhD · Nord University

Eligibility

Min Age
65 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-07-30
Primary Completion
2021-09-15
Completion
2021-09-15

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04884711 on ClinicalTrials.gov